Inventor · disambiguated record
Premchand Dalichandji Nakhat
Also filed as: NAKHAT PREMCHAND · NAKHAT PREMCHAND DALICHANDJI
7 granted patents·4 pending applications·3 citations·filing 2008–2021
72Inventor score
Files withJUBILANT GENERICS LTD3DABRE RAHUL2NAKHAT PREMCHAND2JAIN GIRISH KUMAR1MADHUKAR KODGULE MANDAR1
Top patents by PatentIndex Score
11 records- 0179US10888519B2Immediate release pharmaceutical composition of iron chelating agentsJUBILANT GENERICS LTD·Filed 2017·Granted Jan 12, 2021·2 cites·19 claims
- 0272US10918604B2Solid oral dosage forms of eslicarbazepineJUBILANT GENERICS LTD·Filed 2016·Granted Feb 16, 2021·1 cites·16 claims
- 0363US8999381B2Self-emulsifying pharmaceutical compositions of rhein or diacereinNAKHAT PREMCHAND·Filed 2008·Granted Apr 7, 2015·0 cites·7 claims
- 0456US2021161823A1Solid oral dosage forms of eslicarbazepineJUBILANT GENERICS LTD·Filed 2021·Application pending·0 cites
- 0554US2011262537A1Extended release dosage form of ropiniroleNAKHAT PREMCHAND·Filed 2009·Application pending·0 cites
- 0649US9192596B2Self-emulsifying pharmaceutical compositions of rhein or diacereinWOCKHARDT RESEARCH CENTER·Filed 2015·Granted Nov 24, 2015·0 cites·6 claims
- 0746US8821924B2Rhein or diacerein compositionsDABRE RAHUL·Filed 2008·Granted Sep 2, 2014·0 cites·6 claims
- 0840US2014329781A1Methods for treating cardiovascular disorderWOCKHARDT LTD·Filed 2012·Application pending·0 cites
- 0939US2014302126A1Rhein or diacerein compositionsDABRE RAHUL·Filed 2014·Application pending·0 cites
- 1035US9408814B2Modified release dosage form comprising desvenlafaxine or salts thereofJAIN GIRISH KUMAR·Filed 2011·Granted Aug 9, 2016·0 cites·2 claims
- 1130US9446032B2Methods for treating cardiovascular disordersMADHUKAR KODGULE MANDAR·Filed 2012·Granted Sep 20, 2016·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Premchand Dalichandji Nakhat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →